Who
Jon Winkelried
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Tpg; 10% owner, TPG Twin Brook Capital Income Fund; 10% owner, Sionna Therapeutics; Other, Beta Technologies; Other, Life Time Group Holdings; Other, Nerdy; 10% owner, LifeStance Health Group; 10% owner, Nextpower.
In numbers
- Trades disclosed
- 237
- Buys
- 2
- Sells
- 35
- Bought
- $150.0M
- Sold
- $1.1B
- Companies
- 13
- Companies where not an officer
- 11
- First trade
- 15 Sep 2006
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —1,152 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —357 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —179 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —1,152 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —357 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —179 at $0.00 | filing |
| 29 Jul 2026filed 31 Jul 2026 | TPG Twin Brook Capital Income Fund | SEC FORM 4 Bought | $50.0M1,984,182.1 at $25.20 | filing |
| 29 Jun 2026filed 1 Jul 2026 | TPG Twin Brook Capital Income Fund | SEC FORM 4 Bought | $100.0M3,966,554.02 at $25.21 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —67,353 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —21,032 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —10,509 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —67,353 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —21,032 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —10,509 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | SION Sionna TherapeuticsBiotechnology | SEC FORM 4 Sold | $10.0M250,000 at $40.00 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code F | $27.5M415,739 at $66.03 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —499,511 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code M | —583,821 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code M | —583,821 at $0.00 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code M | —583,821 at $0.00 | filing |
News
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis ConferenceSION · manilatimes.net · 8 Oct 2026
0 headlines in the last 90 days name Jon Winkelried; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.